Drug General Information
Drug ID	D06QFO
Former ID	DNC004861
Drug Name	(5-(pyridin-3-yl)furan-2-yl)methanamine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528540]
Structure		Download 2D MOL 3D MOL
Formula	C10H10N2O
Canonical SMILES	C1=CC(=CN=C1)C2=CC=C(O2)CN
InChI	1S/C10H10N2O/c11-6-9-3-4-10(13-9)8-2-1-5-12-7-8/h1-5,7H,6,11H2
InChIKey	LENAVORGWBTPJR-UHFFFAOYSA-N
PubChem Compound ID	11332763
Target and Pathway
Target(s)	Cytochrome P450 2D6	Target Info	Inhibitor	[528540]
KEGG Pathway	Metabolism of xenobiotics by cytochrome P450
	Drug metabolism - cytochrome P450
	Serotonergic synapse
Reactome	Xenobiotics
WikiPathways	Metapathway biotransformation
	Tamoxifen metabolism
	Oxidation by Cytochrome P450
	Vitamin D Receptor Pathway
	Aripiprazole Metabolic Pathway
	Fatty Acid Omega Oxidation
	Codeine and Morphine Metabolism
References
Ref 528540	J Med Chem. 2006 Nov 30;49(24):6987-7001.Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.
Ref 528540	J Med Chem. 2006 Nov 30;49(24):6987-7001.Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.